157 related articles for article (PubMed ID: 12538353)
1. beta-Catenin mutation is selected during malignant transformation in colon carcinogenesis.
Yamada Y; Oyama T; Hirose Y; Hara A; Sugie S; Yoshida K; Yoshimi N; Mori H
Carcinogenesis; 2003 Jan; 24(1):91-7. PubMed ID: 12538353
[TBL] [Abstract][Full Text] [Related]
2. Frequent beta-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis.
Yamada Y; Yoshimi N; Hirose Y; Kawabata K; Matsunaga K; Shimizu M; Hara A; Mori H
Cancer Res; 2000 Jul; 60(13):3323-7. PubMed ID: 10910031
[TBL] [Abstract][Full Text] [Related]
3. Predominant mutation of codon 41 of the beta-catenin proto-oncogene in rat colon tumors induced by 1,2-dimethylhydrazine using a complete carcinogenic protocol.
Koesters R; Hans MA; Benner A; Prosst R; Boehm J; Gahlen J; Doeberitz MK
Carcinogenesis; 2001 Nov; 22(11):1885-90. PubMed ID: 11698353
[TBL] [Abstract][Full Text] [Related]
4. Gene mutations and altered gene expression in azoxymethane-induced colon carcinogenesis in rodents.
Takahashi M; Wakabayashi K
Cancer Sci; 2004 Jun; 95(6):475-80. PubMed ID: 15182426
[TBL] [Abstract][Full Text] [Related]
5. Altered expression of beta-catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azoxymethane-induced rat colon carcinogenesis.
Takahashi M; Mutoh M; Kawamori T; Sugimura T; Wakabayashi K
Carcinogenesis; 2000 Jul; 21(7):1319-27. PubMed ID: 10874009
[TBL] [Abstract][Full Text] [Related]
6. Mutational and nonmutational activation of p21ras in rat colonic azoxymethane-induced tumors: effects on mitogen-activated protein kinase, cyclooxygenase-2, and cyclin D1.
Bissonnette M; Khare S; von Lintig FC; Wali RK; Nguyen L; Zhang Y; Hart J; Skarosi S; Varki N; Boss GR; Brasitus TA
Cancer Res; 2000 Aug; 60(16):4602-9. PubMed ID: 10969813
[TBL] [Abstract][Full Text] [Related]
7. Frequent mutations of the beta-catenin gene in mouse colon tumors induced by azoxymethane.
Takahashi M; Nakatsugi S; Sugimura T; Wakabayashi K
Carcinogenesis; 2000 Jun; 21(6):1117-20. PubMed ID: 10836998
[TBL] [Abstract][Full Text] [Related]
8. K-ras mutations in aberrant crypt foci, adenomas and adenocarcinomas during azoxymethane-induced colon carcinogenesis.
Vivona AA; Shpitz B; Medline A; Bruce WR; Hay K; Ward MA; Stern HS; Gallinger S
Carcinogenesis; 1993 Sep; 14(9):1777-81. PubMed ID: 8403199
[TBL] [Abstract][Full Text] [Related]
9. Analysis of beta-catenin, Ki-ras, and microsatellite stability in azoxymethane-induced colon tumors of BDIX/Orl Ico rats.
Sørensen NM; Kobaek-Larsen M; Bonne A; van Zutphen B; Fenger C; Kristiansen K; Ritskes-Hoitinga M
Comp Med; 2003 Dec; 53(6):633-8. PubMed ID: 14727811
[TBL] [Abstract][Full Text] [Related]
10. Mutational analysis of Ctnnb1 and Apc in tumors from rats given 1,2-dimethylhydrazine or 2-amino-3-methylimidazo[4,5-f]quinoline: mutational 'hotspots' and the relative expression of beta-catenin and c-jun.
Blum CA; Tanaka T; Zhong X; Li Q; Dashwood WM; Pereira C; Xu M; Dashwood RH
Mol Carcinog; 2003 Apr; 36(4):195-203. PubMed ID: 12669311
[TBL] [Abstract][Full Text] [Related]
11. Beta-Catenin mutations in a mouse model of inflammation-related colon carcinogenesis induced by 1,2-dimethylhydrazine and dextran sodium sulfate.
Kohno H; Suzuki R; Sugie S; Tanaka T
Cancer Sci; 2005 Feb; 96(2):69-76. PubMed ID: 15723650
[TBL] [Abstract][Full Text] [Related]
12. Beta-catenin is frequently mutated and demonstrates altered cellular location in azoxymethane-induced rat colon tumors.
Takahashi M; Fukuda K; Sugimura T; Wakabayashi K
Cancer Res; 1998 Jan; 58(1):42-6. PubMed ID: 9426055
[TBL] [Abstract][Full Text] [Related]
13. beta-Catenin mutation in rat colon tumors initiated by 1,2-dimethylhydrazine and 2-amino-3-methylimidazo[4,5-f]quinoline, and the effect of post-initiation treatment with chlorophyllin and indole-3-carbinol.
Blum CA; Xu M; Orner GA; Fong AT; Bailey GS; Stoner GD; Horio DT; Dashwood RH
Carcinogenesis; 2001 Feb; 22(2):315-20. PubMed ID: 11181454
[TBL] [Abstract][Full Text] [Related]
14. Mucin-depleted foci have beta-catenin gene mutations, altered expression of its protein, and are dose- and time-dependent in the colon of 1,2-dimethylhydrazine-treated rats.
Femia AP; Bendinelli B; Giannini A; Salvadori M; Pinzani P; Dolara P; Caderni G
Int J Cancer; 2005 Aug; 116(1):9-15. PubMed ID: 15751047
[TBL] [Abstract][Full Text] [Related]
15. Characterization of dysplastic aberrant crypt foci in the rat colon induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
Ochiai M; Ushigome M; Fujiwara K; Ubagai T; Kawamori T; Sugimura T; Nagao M; Nakagama H
Am J Pathol; 2003 Oct; 163(4):1607-14. PubMed ID: 14507667
[TBL] [Abstract][Full Text] [Related]
16. High frequency of beta-catenin (ctnnb1) mutations in the colon tumors induced by two heterocyclic amines in the F344 rat.
Dashwood RH; Suzui M; Nakagama H; Sugimura T; Nagao M
Cancer Res; 1998 Mar; 58(6):1127-9. PubMed ID: 9515794
[TBL] [Abstract][Full Text] [Related]
17. Different mutation status of the beta-catenin gene in carcinogen-induced colon, brain, and oral tumors in rats.
Suzui M; Sugie S; Mori H; Okuno M; Tanaka T; Moriwaki H
Mol Carcinog; 2001 Dec; 32(4):206-12. PubMed ID: 11746832
[TBL] [Abstract][Full Text] [Related]
18. Enhanced colon carcinogenesis induced by azoxymethane in min mice occurs via a mechanism independent of beta-catenin mutation.
Suzui M; Okuno M; Tanaka T; Nakagama H; Moriwaki H
Cancer Lett; 2002 Sep; 183(1):31-41. PubMed ID: 12049812
[TBL] [Abstract][Full Text] [Related]
19. Frequent mutations of the rat beta-catenin gene in colon cancers induced by methylazoxymethanol acetate plus 1-hydroxyanthraquinone.
Suzui M; Ushijima T; Dashwood RH; Yoshimi N; Sugimura T; Mori H; Nagao M
Mol Carcinog; 1999 Mar; 24(3):232-7. PubMed ID: 10204808
[TBL] [Abstract][Full Text] [Related]
20. More frequent beta-catenin gene mutations in adenomas than in aberrant crypt foci or adenocarcinomas in the large intestines of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-treated rats.
Tsukamoto T; Tanaka H; Fukami H; Inoue M; Takahashi M; Wakabayashi K; Tatematsu M
Jpn J Cancer Res; 2000 Aug; 91(8):792-6. PubMed ID: 10965019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
